FEATURE ARTICLES
The pharma/biotech industry must ramp up adoption of digital certificates of analysis, which are transforming the way quality data is transferred between organizations in the supply chain.
- 7 Focus Areas To Establish A Win-Win Relationship With Your CDMO
- Deploy AI To Become A cGMP "Special Agent" With A License To Care
- 11 Key Contributing Factors For Maintaining Sterility Assurance
- Here's Why The Life Sciences Struggle To Exploit Process Knowledge
- December 2024 — CDMO Opportunities And Threats Report
- ASTM International Pharmaceutical Cleaning Standards: Current Status And Future Direction
- AI's Promising Role In Adverse Event Management Of Small Molecule Drugs
PHARMA ONLINE WHITE PAPERS
-
Best Practices In Commissioning And Qualification
An integrated approach to C&Q ensures coordination and synchronization between commissioning and qualification activities, enhancing both regulatory compliance and product safety.
-
Accelerated API Manufacturing: Combining All Process Development Stages5/16/2024
During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.
-
The Advantages Of A Blended Learning Approach In Operator Training5/30/2024
Explore blended learning and its advantages over traditional operator training methods, which often reduce training to a repetitive but necessary checklist of reading and acknowledging procedures.
-
The State Of Plastics Recycling In BioPharma8/9/2023
Recycling plastics from biomanufacturing proves uniquely difficult due to circularity, quality, and infrastructure challenges. Nonetheless, change is underway. Learn how this change is being spearheaded by industry leaders.
-
Sustainable Solutions For Medical Devices1/6/2025
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, reducing carbon footprints by up to 70%.
-
Transitioning Your Product From Phase 1 To Phase 2 Clinical Studies12/13/2024
Strategic partnerships can streamline your transition from Phase 1 to Phase 2 clinical studies, ensuring optimized dosage forms, seamless scale-up, and alignment with patient and study requirements.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Successful DPM Manufacturing- Development To Large-Scale cGMP Production
- Getting CMC Right For Emerging Technologies
- Reagents For Highly Efficient T Cell Manufacturing
- Direct And Rapid Multi-Attribute Monitoring Of Multiple Intact mAbs
- Method Migration Of The USP Ibuprofen Assay And Organic Impurities Method
NEWSLETTER ARCHIVE
- 01.23.25 -- ASTM International Pharmaceutical Cleaning Standards: Current Status And Future Direction
- 01.23.25 -- STREAM Edition: Trusted Tools And Strategies Tailored For The Pharmaceutical Industry
- 01.22.25 -- Minimize Risk To Maximize Yield: 4 Questions To Ask Your Fill/Finish Partner
- 01.21.25 -- Will 2025 be the year you go end-to-end with your digital transformation?
- 01.21.25 -- AI's Promising Role In Adverse Event Management Of Small Molecule Drugs
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content Collections